SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-17-002109
Filing Date
2017-03-29
Accepted
2017-03-29 07:01:04
Documents
5
Effectiveness Date
2017-03-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2231578zdefa14a.htm DEFA14A 48743
2 G1003878.JPG g1003878.jpg GRAPHIC 30375
3 G442580.JPG g442580.jpg GRAPHIC 57862
4 G91517.JPG g91517.jpg GRAPHIC 48425
5 G714624.JPG g714624.jpg GRAPHIC 31914
  Complete submission text file 0001047469-17-002109.txt   282677
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 17720641
SIC: 2834 Pharmaceutical Preparations